Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories
PRISMA-2, NCT02086786: Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia

Completed
2
70
US
Risperidone ISM, No other names
Rovi Pharmaceuticals Laboratories
Schizophrenia
03/15
03/15

Download Options